[HTML][HTML] A multiscale model of epigenetic heterogeneity-driven cell fate decision-making

N Folguera-Blasco, R Pérez-Carrasco… - PLoS computational …, 2019 - journals.plos.org
The inherent capacity of somatic cells to switch their phenotypic status in response to damage
stimuli in vivo might have a pivotal role in ageing and cancer. However, how the entry-exit …

Mitostemness

E Cuyàs, S Verdura, N Folguera-Blasco… - Cell Cycle, 2018 - Taylor & Francis
… Núria Folguera-Blasco and Tomás Alarcón acknowledge MINECO for funding under grant
MTM2015-71509-C2-1-R and AGAUR for funding under grant 2014 SGR1307. The authors …

[HTML][HTML] Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model

N Folguera-Blasco, E Cuyàs… - PLoS computational …, 2018 - journals.plos.org
Understanding the control of epigenetic regulation is key to explain and modify the aging
process. Because histone-modifying enzymes are sensitive to shifts in availability of cofactors (…

[HTML][HTML] Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome

JA Menendez, N Folguera-Blasco, E Cuyàs… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The geroncogenesis hypothesis postulates that the decline in metabolic cellular health that
occurs naturally with aging drives a “field effect” predisposing normal tissues for cancer …

[HTML][HTML] In silico clinical trials for anti-aging therapies

JA Menendez, E Cuyàs, N Folguera-Blasco… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Therapeutic strategies targeting the hallmarks of aging can be broadly grouped into four
categories, namely systemic (blood) factors, metabolic manipulation (diet regimens and dietary …

A multiscale model of epigenetic heterogeneity reveals the kinetic routes of pathological cell fate reprogramming

N Folguera-Blasco, R Pérez-Carrasco, E Cuyas… - bioRxiv, 2018 - biorxiv.org
The inherent capacity of somatic cells to switch their phenotypic status in response to damage
stimuli in vivo might have a pivotal role in ageing and cancer. However, how the entry-exit …

In silico clinical trials for anti-aging therapies

…, E Cuyàs, N Folguera Blasco… - Aging-Us, 2019, vol …, 2019 - dugi-doc.udg.edu
Therapeutic strategies targeting the hallmarks of aging can be broadly grouped into four
categories, namely systemic (blood) factors, metabolic manipulation (diet regimens and dietary …

Exploiting Homeostatic Repopulation to Increase DC Vaccine Efficacy in Multiple Myeloma

CD Gatenbee, N Folguera-Blasco, C Daneils… - bioRxiv, 2016 - biorxiv.org
Standard of care for multiple myeloma involves au-tologous hematopoietic cell transplant (AHCT),
which can extend life by a year; however the disease remains incurable. A dendritic …

[PDF][PDF] Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive computational model Supporting information

N Folguera-Blasco, E Cuyas, JA Menéndez, T Alarcón - pdfs.semanticscholar.org
In this appendix, we present supplementary materials regarding the methods of our
manuscript Epigenetic regulation of cell fate reprogramming in aging and disease: A predictive …

Patología de pared abdominal

MF Blasco, B de Pablo Márquez, AA Genicio - FMC-Formación Médica …, 2022 - Elsevier
… Author links open overlay panel Mercè Folguera Blasco a , Bernat de Pablo Márquez a b
, … N Engl J Med., 350 (18) (2004), pp. 1819-1827 … Paterson, N. Scott, A. Hair, PJ O'Dwyer …